|Teva Announces Newly Named Grant Program and 2015 Awardees at Boston Symposium|
Teva recognizes that great medicines begin with great science. In 2008, under the leadership and guidance of Richard Egosi, Group Executive Vice President and Chief Legal Officer and Marc Goshko, Vice President, Product & Patent Strategy, Teva initiated the Teva Pharmaceuticals Scholars Grant Program to provide research funds to recently tenured university professors whose work was related to organic and medicinal chemistry. Since that time, Teva has provided nearly $2 million dollars in grant funding for important research in various areas such as natural product synthesis, liposomes, modification of microRNA and synthetic lectins.
This year, in honor of Marc, Teva has re-established the Teva Pharmaceutical Scholars Grant Program, now known as the Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program.
At the American Chemical Society’s National Meeting and Exhibition in August 2015, Teva had the honor of hosting a symposium featuring presentations from the program’s 2012-2015 winners. At the symposium held in Boston, we also unveiled the newly named program and announced the three new grant winners.
The recipients of the 2015-2018 Teva Pharmaceuticals Mark A. Goshko Memorial Grant Program are:
We’re very pleased, in honor of Marc, to continue this tradition of "Leading the Way" by supporting this important academic research in the areas of organic and medicinal chemistry.